Ex Vivo Model of Neuroblastoma Plasticity

Standard

Ex Vivo Model of Neuroblastoma Plasticity. / Schäfer, Paula; Muhs, Stefanie; Turnbull, Lucas; Garwal, Palwasha; Maar, Hanna; Yorgan, Timur A; Tolosa, Eva; Lange, Tobias; Windhorst, Sabine.

In: CANCERS, Vol. 15, No. 4, 1274, 17.02.2023.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

APA

Vancouver

Schäfer P, Muhs S, Turnbull L, Garwal P, Maar H, Yorgan TA et al. Ex Vivo Model of Neuroblastoma Plasticity. CANCERS. 2023 Feb 17;15(4). 1274. https://doi.org/10.3390/cancers15041274

Bibtex

@article{767298f7adb643099012a8f5dbb663f0,
title = "Ex Vivo Model of Neuroblastoma Plasticity",
abstract = "Tumor plasticity is essential for adaptation to changing environmental conditions, in particular during the process of metastasis. In this study, we compared morphological and biochemical differences between LAN-1 neuroblastoma (NB) cells recovered from a subcutaneous xenograft primary tumor (PT) and the corresponding three generations of bone metastasis (BM I-III). Moreover, growth behavior, as well as the response to chemotherapy and immune cells were assessed. For this purpose, F-actin was stained, mRNA and protein expression assessed, and lactate secretion analyzed. Further, we measured adhesion to collagen I, the growth rate of spheroids in the presence and absence of vincristine, and the production of IL-6 by peripheral blood mononuclear cells (PBMCs) co-incubated with PT or BM I-III. Analysis of PT and the three BM generations revealed that their growth rate decreased from PT to BM III, and accordingly, PT cells reacted most sensitively to vincristine. In addition, morphology, adaption to hypoxic conditions, as well as transcriptomes showed strong differences between the cell lines. Moreover, BM I and BM II cells exhibited a significantly different ability to stimulate human immune cells compared to PT and BM III cells. Interestingly, the differences in immune cell stimulation corresponded to the expression level of the cancer-testis antigen MAGE-A3. In conclusion, our ex vivo model allows to analyze the adaption of tumor populations to different microenvironments and clearly demonstrates the strong alteration of tumor cell populations during this process.",
author = "Paula Sch{\"a}fer and Stefanie Muhs and Lucas Turnbull and Palwasha Garwal and Hanna Maar and Yorgan, {Timur A} and Eva Tolosa and Tobias Lange and Sabine Windhorst",
year = "2023",
month = feb,
day = "17",
doi = "10.3390/cancers15041274",
language = "English",
volume = "15",
journal = "CANCERS",
issn = "2072-6694",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "4",

}

RIS

TY - JOUR

T1 - Ex Vivo Model of Neuroblastoma Plasticity

AU - Schäfer, Paula

AU - Muhs, Stefanie

AU - Turnbull, Lucas

AU - Garwal, Palwasha

AU - Maar, Hanna

AU - Yorgan, Timur A

AU - Tolosa, Eva

AU - Lange, Tobias

AU - Windhorst, Sabine

PY - 2023/2/17

Y1 - 2023/2/17

N2 - Tumor plasticity is essential for adaptation to changing environmental conditions, in particular during the process of metastasis. In this study, we compared morphological and biochemical differences between LAN-1 neuroblastoma (NB) cells recovered from a subcutaneous xenograft primary tumor (PT) and the corresponding three generations of bone metastasis (BM I-III). Moreover, growth behavior, as well as the response to chemotherapy and immune cells were assessed. For this purpose, F-actin was stained, mRNA and protein expression assessed, and lactate secretion analyzed. Further, we measured adhesion to collagen I, the growth rate of spheroids in the presence and absence of vincristine, and the production of IL-6 by peripheral blood mononuclear cells (PBMCs) co-incubated with PT or BM I-III. Analysis of PT and the three BM generations revealed that their growth rate decreased from PT to BM III, and accordingly, PT cells reacted most sensitively to vincristine. In addition, morphology, adaption to hypoxic conditions, as well as transcriptomes showed strong differences between the cell lines. Moreover, BM I and BM II cells exhibited a significantly different ability to stimulate human immune cells compared to PT and BM III cells. Interestingly, the differences in immune cell stimulation corresponded to the expression level of the cancer-testis antigen MAGE-A3. In conclusion, our ex vivo model allows to analyze the adaption of tumor populations to different microenvironments and clearly demonstrates the strong alteration of tumor cell populations during this process.

AB - Tumor plasticity is essential for adaptation to changing environmental conditions, in particular during the process of metastasis. In this study, we compared morphological and biochemical differences between LAN-1 neuroblastoma (NB) cells recovered from a subcutaneous xenograft primary tumor (PT) and the corresponding three generations of bone metastasis (BM I-III). Moreover, growth behavior, as well as the response to chemotherapy and immune cells were assessed. For this purpose, F-actin was stained, mRNA and protein expression assessed, and lactate secretion analyzed. Further, we measured adhesion to collagen I, the growth rate of spheroids in the presence and absence of vincristine, and the production of IL-6 by peripheral blood mononuclear cells (PBMCs) co-incubated with PT or BM I-III. Analysis of PT and the three BM generations revealed that their growth rate decreased from PT to BM III, and accordingly, PT cells reacted most sensitively to vincristine. In addition, morphology, adaption to hypoxic conditions, as well as transcriptomes showed strong differences between the cell lines. Moreover, BM I and BM II cells exhibited a significantly different ability to stimulate human immune cells compared to PT and BM III cells. Interestingly, the differences in immune cell stimulation corresponded to the expression level of the cancer-testis antigen MAGE-A3. In conclusion, our ex vivo model allows to analyze the adaption of tumor populations to different microenvironments and clearly demonstrates the strong alteration of tumor cell populations during this process.

U2 - 10.3390/cancers15041274

DO - 10.3390/cancers15041274

M3 - SCORING: Journal article

C2 - 36831616

VL - 15

JO - CANCERS

JF - CANCERS

SN - 2072-6694

IS - 4

M1 - 1274

ER -